<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Sebascuevas</id>
	<title>WikEM - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Sebascuevas"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/wiki/Special:Contributions/Sebascuevas"/>
	<updated>2026-04-22T21:55:43Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Pericarditis&amp;diff=51890</id>
		<title>Pericarditis</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Pericarditis&amp;diff=51890"/>
		<updated>2016-02-08T10:31:11Z</updated>

		<summary type="html">&lt;p&gt;Sebascuevas: /* Disposition */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Background==&lt;br /&gt;
===Etiology===&lt;br /&gt;
*Idiopathic (25-85%)&lt;br /&gt;
*Infection (up to 20%, including viral, bacterial, TB)&lt;br /&gt;
*Malignancy: heme, lung, breast&lt;br /&gt;
*Uremia&lt;br /&gt;
*Post radiation&lt;br /&gt;
*Connective tissue dz&lt;br /&gt;
*Drugs: procainamide, hydralazine, methyldopa, anticoagulants&lt;br /&gt;
*Cardiac injury (can see up to weeks later): post MI (Dressler's syndrome), trauma, aortic dissection&lt;br /&gt;
*Troponin elevation may indicate a concurrent myocarditis which predispose to risk of [[CHF]] or [[arrhythmias|arrhythmia]]. &amp;lt;ref&amp;gt;LeWinter MM, et al. Clinical practice. Acute pericarditis. N Engl J Med. 2014 Dec 18;371(25):2410-6. PMID: 25517707.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Clinical Features==&lt;br /&gt;
*Pleuritic [[chest pain]]&lt;br /&gt;
**Radiates to chest, back, left trapezius&lt;br /&gt;
**Diminishes w/ sitting up/leaning forward&lt;br /&gt;
*[[SOB]]&lt;br /&gt;
**Esp if concommitant [[pleural effusion]]&lt;br /&gt;
*Hypotension/extremis if [[cardiac tamponade]]&lt;br /&gt;
*[[Fever]]&lt;br /&gt;
*Friction rub&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis==&lt;br /&gt;
*[[CHF]]&lt;br /&gt;
*[[PE]]&lt;br /&gt;
*[[Pneumothorax]]&lt;br /&gt;
*[[Aortic dissection]]&lt;br /&gt;
*[[Pneumomediastinum]]&lt;br /&gt;
*[[Pleuritis]]&lt;br /&gt;
&lt;br /&gt;
{{ST elevation DDX}}&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
===Work-Up===&lt;br /&gt;
*ECG&lt;br /&gt;
*Labs&lt;br /&gt;
**WBC, ESR, trop&lt;br /&gt;
*CXR&lt;br /&gt;
*Bedside Ultrasound to r/o effusion&lt;br /&gt;
&lt;br /&gt;
===ECG===&lt;br /&gt;
[[File:ECG000026-2.jpg|thumb|Acute pericarditis with clear diffuse ST elevation and some PTa depression]]&lt;br /&gt;
*[[ECG]]&lt;br /&gt;
**Classically described to cause diffuse ST elevations&lt;br /&gt;
**Less reliable in post-MI pts and those w/ baseline ECG abnormalities&lt;br /&gt;
**May see low voltage/alternans if effusion present&lt;br /&gt;
**If early repol confounding interpretation check ST:T ratio&lt;br /&gt;
***If (ST elev)/(T height) in V6 or I &amp;gt;0.25 likely pericarditis&lt;br /&gt;
&lt;br /&gt;
====Stages of Progression====&lt;br /&gt;
[[File:Stadia pericarditis.png|thumb|Stages of pericarditis]]&lt;br /&gt;
[[File:Ptadepressie.png|thumb|PTa depression]]&lt;br /&gt;
*Stage I:  &lt;br /&gt;
**Global concave up [[ST elevation]] in all leads (esp V4-6, I, II) in all leads except in aVR, V1 and III&lt;br /&gt;
**PTa depression (depression between the end of the P-wave and the beginning of the QRS- complex) &lt;br /&gt;
*Stage II:  &lt;br /&gt;
**&amp;quot;pseudonormalisation,&amp;quot; ST to baseline, big T's, PR dep &lt;br /&gt;
*Stage III:  &lt;br /&gt;
**T wave flatten then inversion&lt;br /&gt;
*Stage IV:  &lt;br /&gt;
**Return to baseline&lt;br /&gt;
&lt;br /&gt;
===[[STEMI]] vs [[Pericarditis]]===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''[[MI]]'''&lt;br /&gt;
| '''[[Pericarditis]]'''&lt;br /&gt;
|-&lt;br /&gt;
| no fever&lt;br /&gt;
| &lt;br /&gt;
fever&lt;br /&gt;
&lt;br /&gt;
pain varies w/motion&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| focal ST chgs&lt;br /&gt;
| diffuse ST elev&lt;br /&gt;
|-&lt;br /&gt;
| reciprocal chgs&lt;br /&gt;
| no reciprocal chgs&lt;br /&gt;
|-&lt;br /&gt;
| Q waves&lt;br /&gt;
| no Q wave&lt;br /&gt;
|-&lt;br /&gt;
| +/- pulm edema&lt;br /&gt;
| clear lungs&lt;br /&gt;
|-&lt;br /&gt;
| wall motion abn&lt;br /&gt;
| nl wall motion&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
===Initial Treatment===&lt;br /&gt;
*'''NSAIDS or Aspirin (ASA)''' are usually first line treatment for viral or idiopathic pericarditis.&amp;lt;ref&amp;gt;Imazio M. A randomized trial of colchicine for acute pericarditis.N Engl J Med. 2013 Oct 17;369(16):1522-8 [http://www.nejm.org/doi/pdf/10.1056/NEJMoa1208536 PDF]&amp;lt;/ref&amp;gt;&lt;br /&gt;
**[[Aspirin]] 800 mg every 8 hours for 7 to 10 days, followed by tapering during a period of 3 to 4 weeks  OR&lt;br /&gt;
**[[Ibuprofen]] 600 mg every 8 hours for 7 to 10 days, followed by tapering during a period of 3 to 4 weeks&lt;br /&gt;
*'''Glucocorticoid therapy''' for patients contraindications to [[NSAIDs]]&lt;br /&gt;
**[[Prednisone]] 0.2 to 0.5 mg/kg of body weight per day for 2 weeks with gradual tapering&amp;lt;ref&amp;gt;Imazio M, Brucato A, Cumetti D, et al. Corticosteroids for recurrent pericar- ditis: high versus low doses: a nonran- domized observation. Circulation 2008; 118:667-71.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Recurrent or Refractory===&lt;br /&gt;
''For recurrent or refractory cases consider colchicine and or steroids although literature suggests it can be used as first line''&amp;lt;ref&amp;gt;Imazio M.Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch Intern Med. 2005 Sep 26;165(17):1987-91.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*'''[[Colchicine]]'''&lt;br /&gt;
**Patients &amp;gt;70kg - 0.6mg PO BID x3months&lt;br /&gt;
**Patients&amp;lt;70kg - 0.6mg PO Daily x 3 months&lt;br /&gt;
**If patients develop serious diarrhea decrease their dosing to the next weight class or stop treatment.&lt;br /&gt;
&lt;br /&gt;
====Contraindications to Colchicine&amp;lt;ref&amp;gt;Imazio M. Controversial issues in the management of pericardial diseases.Circulation. 2010 Feb 23;121(7):916-28.[http://circ.ahajournals.org/content/121/7/916.long PDF] &amp;lt;/ref&amp;gt;====&lt;br /&gt;
*Tuberculous&lt;br /&gt;
*Neoplastic pericarditis&lt;br /&gt;
*Liver disease or aminotransferase levels ≥1.5x upper limits of normal&lt;br /&gt;
*Creatinine &amp;gt;2.5 mg/dL (&amp;gt;221 umol/L)&lt;br /&gt;
*Myopathy or CK &amp;gt; upper limits of normal&lt;br /&gt;
*Inflammatory bowel disease&lt;br /&gt;
*Life expectancy ≤18 months&lt;br /&gt;
*Pregnancy or lactation&lt;br /&gt;
&lt;br /&gt;
===Uremic Pericarditis===&lt;br /&gt;
*The definitive treatment is dialysis&lt;br /&gt;
&lt;br /&gt;
===[[Pericardial effusion and tamponade|Tamponade]]===&lt;br /&gt;
*Tamponade requires  [[Pericardiocentesis]]&lt;br /&gt;
&lt;br /&gt;
== Disposition ==&lt;br /&gt;
*Hospitalization is not necessary in most cases &lt;br /&gt;
*Consider admission for:&lt;br /&gt;
**Subacute onset over weeks&lt;br /&gt;
**[[Fever]] &amp;gt;100.4&lt;br /&gt;
**Large effusion (echo-free space&amp;gt;20mm)&lt;br /&gt;
**Immunosupressed&lt;br /&gt;
**Anticoagulant use&lt;br /&gt;
**Failure to respond to [[NSAID]] Rx (&amp;gt;7dy)&lt;br /&gt;
**Elevated cardiac enzymes&lt;br /&gt;
&lt;br /&gt;
== Complications ==&lt;br /&gt;
*[[Pericardial Effusion and Tamponade]]&lt;br /&gt;
*Recurence&lt;br /&gt;
**Usually weeks to months after initial episode&lt;br /&gt;
**Management is same&lt;br /&gt;
*Contrictive Pericarditis&lt;br /&gt;
**Restrictive picture with pericardial calcifications on CXR, thickened on TTE&lt;br /&gt;
**Treat with pericardial window&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[ST segment elevation]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Cards]]&lt;/div&gt;</summary>
		<author><name>Sebascuevas</name></author>
	</entry>
</feed>